* FRT: Pharmacy to contribute major earnings over next five years – Update * KBC: Trang Due 3 IP to obtain investment approval in H2 2023 – Update * SCS: Weak trade activity delays new client acquisition – Update * TLG: Higher valuation for defensive busi